T. Yano

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
T Yano, T. Yano, Takahiro Yano
Publication record
78 papers · 2,532 citations · H-index 21

PAPERS

Importance of Compliance With Guidelines for the Prevention of Varicella-Zoster Virus Reactivation in Multiple Myeloma
20214 citationsauthor #9
[Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier].
20210 citationsauthor #4
Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients
20203 citationsauthor #10
Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma
20207 citationsauthor #2
Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma
20202 citationsauthor #10
The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis
201822 citationsauthor #10
Action to pesticide residue analysis of agricultural products before shipping in Ehime Prefecture
20180 citationsauthor #2
R-mini CHP in ≥80-year-old Patients with Diffuse Large B-cell Lymphoma: A Multicenter, Open-label, Single-arm Phase II Trial Protocol.
20181 citationsauthor #3
[Occurrence of acquired factor V inhibitor during antibiotic therapy for a surgical wound infection].
20181 citationsauthor #6
Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults
20189 citationsauthor #2
Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-host Disease
20173 citationsauthor #6
Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma
20171 citationsauthor #8
Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies.
20172 citationsauthor #1
A massive cavitary lesion invading the chest wall.
20150 citationsauthor #8
[Relapsed/refractory multiple myeloma with CD138 shedding and formation of extramedullary disease in the common bile duct region presenting as obstructive jaundice].
20150 citationsauthor #11
Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy
201515 citationsauthor #3
A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study
201514 citationsauthor #18
Oral beclomethasone dipropionate successfully controls gastrointestinal graft-versus-host disease without affecting systemic graft-versus-leukemia effect in blastic phase chronic myeloid leukemia
20150 citationsauthor #8
Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia
20143 citationsauthor #9
Rituximab As Second-Line Treatment For Chronic Immune Thrombocytopenia: Investigator-Initiated Clinical Trial In Japan
20130 citationsauthor #3
Intensified Rituximab Induction Followed By Rituximab Maintenance For Low Grade B Cell Lymphoma: A Multicenter, Phase II Study
20130 citationsauthor #8
Brisk Elevation of Serum Lactate Dehydrogenase During G-CSF Priming is a Significant Predictor for the Ensuing Successful Autologous Peripheral Blood Stem Cell Collection
20130 citationsauthor #9
P2–103GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) -PRODUCING METASTATIC BONE TUMORS OF THE UNKNOWN PRIMARY SITE
20130 citationsauthor #10
Bendamustine can severely impair T-cell immunity against cytomegalovirus
201338 citationsauthor #9
Impact Of Sex On Clinical Outcomes Of Mature B Cell Lymphoma In The Rituximab Era: A Multicenter, Retrospective Study
20130 citationsauthor #4
[Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
20130 citationsauthor #10
Critical Roles of a Dendritic Cell Subset Expressing a Chemokine Receptor, XCR1
2013156 citationsauthor #8
Expressing a Chemokine Receptor, XCR1 Critical Roles of a Dendritic Cell Subset
20130 citationsauthor #8
Spinal Cord Compression: An Unusual Complication of Follicular Lymphoma
20120 citationsauthor #8
Spi-B is critical for plasmacytoid dendritic cell function and development.
201287 citationsauthor #5
[Bleeding tendency].
20122 citationsauthor #2
Sasaki, I. et al. Spi-B is crucial for plasmacytoid dendritic cell function and development. Blood 120, 4733-4743
20121 citationsauthor #5
Prognostic impact of extranodal involvement in diffuse large B‐cell lymphoma in the rituximab era
201298 citationsauthor #5
Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups
20126 citationsauthor #3
Central nervous system event in patients with diffuse large B‐cell lymphoma in the rituximab era
201281 citationsauthor #10
Prognostic Significance of Pre-Transplantation FDG-PET/CT in Patients Who Undergo Allogenic Stem Cell Transplantation for Lymphoma
20111 citationsauthor #11
Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission.
201173 citationsauthor #16
cell lymphomas Histogenetic correlations between subcategories of small noncleaved
20110 citationsauthor #1
Prognostic impact for different sites of extranodal involvement in patients with diffuse large B-cell lymphoma in the rituximab era.
20111 citationsauthor #5
lymphomas MYC rearrangements in histologically progressed follicular
20110 citationsauthor #1
CuttingEdge:CriticalRoleof IkBKinasea inTLR7/9-Induced Type I IFN Production by Conventional Dendritic Cells
20100 citationsauthor #4
Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice.
201046 citationsauthor #8
Cutting Edge: Critical Role of IκB Kinase α in TLR7/9-Induced Type I IFN Production by Conventional Dendritic Cells
201031 citationsauthor #4
Central Nervous System Events In Patients with Diffuse Large B-Cell Lymphoma In the Rituximab Era
20101 citationsauthor #10
A case of age-related EBV-associated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearances, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the other of a large-cell lymphoma
20096 citationsauthor #5
Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma
200811 citationsauthor #2
Isochromosome i(17q) as a sole cytogenetic abnormality in a case of leukemic transformation from myelodysplastic syndrome (MDS)/myeloproliferative diseases (MPD).
20087 citationsauthor #4
Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
200863 citationsauthor #4
Prognostic Factors Associated with Outcomes of RIC and MAC Hematopoietic Stem Cell Transplantation: An Indication for the Selection of Conditioning
20080 citationsauthor #4
Risk Factors Associated with VOD with RIC and MAC Hematopoietic Stem Cell Transplant and the Early Estimation of VOD
20080 citationsauthor #4
Addition of Rituximab Improves Progression-Free and Overall Survival in Patients with B-Cell Lymphoma Receiving Doxorubicin-Containing Chemotherapy
20070 citationsauthor #6
Cytomegalovirus-associated hemophagocytic syndrome with clonal cytogenetic abnormalities in an elderly male.
20073 citationsauthor #6
Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
20071 citationsauthor #7
Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
200616 citationsauthor #5
[Soft tissue amyloidoma].
20051 citationsauthor #4
neoplasms Molecular analysis of the BCL-3 locus at chromosome 17 q 22 in B-cell
20030 citationsauthor #1
[Epidemiological analysis on many cases of tsutsugamushi disease found in Hiroshima Prefecture, Japan].
20014 citationsauthor #2
Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax
1997105 citationsauthor #7
Mutation of the ras genes is a rare genetic event in the histologic transformation of follicular lymphoma.
199610 citationsauthor #2
Double knockout of the ALL-1 gene blocks hematopoietic differentiation in vitro.
199681 citationsauthor #3
Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies.
1996108 citationsauthor #5
Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences.
1995128 citationsauthor #2
Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies.
1995107 citationsauthor #9
Clustered mutations in the transcriptional activation domain of Myc in 8q24 translocated lymphomas and their functional consequences.
199521 citationsauthor #2
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain
1995155 citationsauthor #4
[Lysosomal membrane transport disorders--cystinosis and sialic acid storage disorders (Salla disease, ISSD)].
19951 citationsauthor #1
Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.
199482 citationsauthor #2
Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms.
199316 citationsauthor #1
p53 mutation is associated with progression in follicular lymphomas.
1993402 citationsauthor #2
MYC rearrangements in histologically progressed follicular lymphomas.
1992248 citationsauthor #1
Lymphoproliferative Lesions in Patients with Common Variable Immunodeficiency Syndrome
1992131 citationsauthor #4
Histogenetic correlations between subcategories of small noncleaved cell lymphomas.
199297 citationsauthor #1
A common Vδ2—Dδ2—Dδ3 T cell receptor gene rearrangement in precursor B acute lymphoblastic leukaemia
199110 citationsauthor #1
A common V delta 2-D delta 2-D delta 3 T cell receptor gene rearrangement in precursor B acute lymphoblastic leukaemia.
19910 citationsauthor #1
Detection of interleukin‐6 (IL‐6) in human bone marrow myeloma cells by light and electron microscopy
19908 citationsauthor #2
Application of the avidin‐biotin‐peroxidase complex technique for ultraimmunocytochemical characterization of leukemic cells
19902 citationsauthor #1
In vitro endocytosis of benign and malignant human bone marrow plasma cells
19903 citationsauthor #2
[Ultrastructural study of erythroblasts in the myelodysplastic syndrome].
19870 citationsauthor #3

TIMELINE

1987 0 citations

1990 13 citations

1991 10 citations

1992 476 citations

1993 418 citations

1994 82 citations

1995 412 citations

1996 199 citations

1997 105 citations

2001 4 citations

2003 0 citations

2005 1 citations

2006 16 citations

2007 4 citations

2008 81 citations

2009 6 citations

2010 78 citations

2011 75 citations

2012 275 citations

2013 194 citations

2014 3 citations

2015 29 citations

2017 6 citations

2018 33 citations

2020 12 citations

2021 4 citations

COAUTHOR MAP

CONCEPT FOOTPRINT